Advertisement

Header Utility Menu

  • Subscribe
  • Advertise
  • Contact Us
  • Events

LinkedIn Facebook Twitter Instagram Get Our App

  • Login

Virginia Business

Mobile Menu

  • Issues
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Legal Elite
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • 2022 Virginia Business Political Roundtable
    • Women in Leadership
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
  • Virginia 500
    • Read The Issue
    • Power Up Virginia 500
    • Buy an award plaque
    • Suggest execs for 2023

Advertisement

Header Primary Menu

  • Issues
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • Issues Archive
  • Industries
    • Banking/Finances
    • Law
    • Real Estate
    • Economic Development
    • Education
    • Energy/Green
    • Federal Contracting
    • Government
    • Healthcare
    • Hotels/Tourism
    • Insurance
    • Ports/Trade
    • Small Business
    • Startups
    • Technology
    • Transportation
  • Regions
    • Central Virginia
    • Eastern Virginia
    • Northern Virginia
    • Roanoke/New River Valley
    • Shenandoah Valley
    • Southern Virginia
    • Southwest Virginia
  • Reports
    • Best Places to Work
    • Business Person of the Year
    • CEO Pay
    • COVID-19
    • Generous Virginians Project
    • Legal Elite
    • Most Influential Virginians
    • Maritime Guide
    • Site Locator
    • The Big Book
    • Virginia CFO Awards
  • Company News
    • For the Record
    • People
  • Opinion
  • Lists
  • Awards/Events
    • 2022 Virginia Business Political Roundtable
    • Women in Leadership
    • Diversity Leadership Series
    • Virginia 500
    • Legal Elite
    • CFO Awards
    • Big Book of Lists
    • 100 People To Meet
    • Best Places To Work
  • Virginia 500
    • Read The Issue
    • Power Up Virginia 500
    • Buy an award plaque
    • Suggest execs for 2023

Home News latest news Virginia Catalyst announces grants for collaborative research projects

Virginia Catalyst announces grants for collaborative research projects

Published June 20, 2017 by Jessica Sabbath

The Virginia Biosciences Health Research Corp., known as Virginia Catalyst, announced Monday it has awarded almost $3 million to six collaborative bioscience commercialization projects in a new round of funding.

Virginia Catalyst is a not-for-profit corporation funded by the Virginia General Assembly’s general fund and seven of Virginia’s research universities. It supports projects that include university and private-sector partners. The organization has now awarded 24 grants totaling $10 million, combined with $20 million in matching funds.

“Virginia’s research universities are providing leadership on a national and global level in the life sciences by combining their intellectual and scientific prowess through collaborations to achieve critical mass,” Mike Grisham, CEO of Virginia Catalyst, said in a statement. “This competitive critical mass is attracting significant outside capital and industry participation to commercialize Virginia’s innovations, while creating high-paying jobs for Virginia.”

The six projects in this round of funding include:

INSPIRE brain cancer treatment:  VoltMed Inc. of Blacksburg and Virginia Tech and the University of Virginia received $800,000 with $1.7 million in matching funds provided by the National Institutes of Health. The company was spun out of U.Va. and is “developing a tumor treatment platform that selectively destroys brain cancer cells, including malignant glioma,” said Chris Arena, Vice President of VoltMed.

Funding from the Virginia Catalyst will support compliance for regulatory manufacturing and testing of the treatment.

BT-11: Oral therapeutic for inflammatory bowel disease: BioTherapeutics Inc. of Blacksburg and Virginia Tech and Virginia Commonwealth University will receive $800,000 with an equal match from the company.

BioTherapeutics is working to develop safer, more effective drugs for people suffering from inflammatory bowel disease. “Our lead compound, BT-11, is an oral first-in-class therapeutic for moderate to severe Crohn's disease and ulcerative colitis,” says Josep Bassaganya-Riera, president and CEO of BioTherapeutics. “We anticipate filing an investigational new drug (IND) for BT-11 and entering Phase 1 and 2 clinical testing in 2018.”

Anti-inflammatory drug with to treat myocardial injury and prevent heart failure: Serpin Pharma of Manassas and George Mason University and Virginia Commonwealth University will receive $400,000 with an equal match provided by the company.

Accelerating  commercialization of the Diamond Mouse Model of nonalcoholic steatohepatitis (NASH, a fatty liver disease): Sanyal Biotechnology of Richmond and Eastern Virginia Medical School and George Mason University will receive $100,000 with a match by Sanyal Biotechnology. The company allows clients to test medicines on mice who have developed NASH.

“Sanyal Bio is committed to developing cures for liver diseases like fatty liver and NASH that result from the twin epidemics of diabetes and obesity,” said Rebecca Caffrey, founder and CEO, Sanyal Biotechnology. “This funding will help in the development of a tissue bank and provide some R&D into mechanisms driving the development of these diseases in our model.  This funding allows us to answer some key questions for our pharmaceutical company clients, so that we can grow our business faster.”

Translational research and pulsed, electric-field technologies for immune-oncology applications: Pulse Biosciences Inc. of Burlingame Calif. and Old Dominion University and Eastern Virginia Medical School will receive $300,000 with a match from the company.

Bioengineering for the therapeutic delivery of massively expanded islet-derived human beta-cells (for treatment of diabetes): Proagenix Inc. of Rockville, Md., and Virginia Commonwealth University and the University of Virginia will receive $425,000 with $1.04 million in matching funds from the National Institutes of Health and Propagenix.

“This Virginia Catalyst research award will propel deployment of a unique combination of capabilities at Virginia Commonwealth University, the University of Virginia and Propagenix to discover new approaches to improve islet transplantation for Type 1 diabetes,” said Brian Pollok, CEO of Propagenix. “The merger of bioengineering and material sciences expertise at these universities, with our proprietary cell expansion technology, has the promise of significantly changing the current equation of human islet cell therapy for patients suffering from this disease.”

Related Stories

First Freedom Center opening set for Jan. 16 in downtown Richmond

Virginia Business logo

Eldor opens auto-parts plant in Botetourt County

Virginia Business logo

Sept. Va. General Fund revenue increases 7.6%

Increase driven by payroll withholding, corporate, recordation tax collection growth

Trending

Norfolk’s MacArthur Center mall listed for sale

Making strides

Fort Monroe development moving forward

Danville lacks housing options for workforce

Manassas company to develop short takeoff, landing aircraft for Air Force

Sponsored Stories

What Logistics issues will have the biggest impact on you in 2023?

In the New Year, Aim for Better Cybersecurity

4 innovative ways to create capacity

WHERE IS THE SUPPLY CHAIN WHEN YOU NEED IT?

P.A.I.N.T. Your Financial Mountain

5 Benefits of Treasury Management Services from Atlantic Union Bank

Blazing trails in the digital landscape

Advertisement

Advertisement

Trending

Norfolk’s MacArthur Center mall listed for sale

Making strides

Fort Monroe development moving forward

Danville lacks housing options for workforce

Manassas company to develop short takeoff, landing aircraft for Air Force

Sponsored Stories

What Logistics issues will have the biggest impact on you in 2023?

In the New Year, Aim for Better Cybersecurity

4 innovative ways to create capacity

WHERE IS THE SUPPLY CHAIN WHEN YOU NEED IT?

P.A.I.N.T. Your Financial Mountain

5 Benefits of Treasury Management Services from Atlantic Union Bank

Blazing trails in the digital landscape

Get Virginia Business directly on your tablet or in your mailbox!

Subscribe to Virginia Business

Advertisement

Advertisement

Footer Primary Menu

  • virginiabusiness.com
  • Subscribe
  • Advertise
  • About Us
  • Contact Us

Footer Secondary Menu

  • Industries
  • Regions
  • Reports
  • Company News
  • Events

Sign Up For Our Newsletter

Sign Up

LinkedIn Facebook Twitter Instagram Get Our App

Privacy Policy Cookie Policy

Footer Utility Menu

Copyright © 2023 Virginia Business. All rights reserved.

Site Maintained by TechArk